Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tezepelumab in patients with allergic and eosinophilic asthma
Marco Caminati, Roland Buhl, Jonathan Corren, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1134-1145
Open Access | Times Cited: 13

Showing 13 citing articles:

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study
Tara F. Carr, Wendy C. Moore, Monica Kraft, et al.
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2978-2990
Open Access | Times Cited: 7
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment
Valentina D’Aiuto, Ilaria Mormile, Francescopaolo Granata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1729-1729
Open Access
Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis
Anish Dsilva, Andreas H. Wagner, Michal Itan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Advances in Asthma-Related Biomarkers
明月 廖
Asian Case Reports in Emergency Medicine (2025) Vol. 13, Iss. 01, pp. 33-43
Closed Access
Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management
S.M. Yan, Bowen Yang, Haichuan Qin, et al.
Inflammation Research (2024) Vol. 73, Iss. 9, pp. 1425-1434
Closed Access | Times Cited: 2
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles
Marco Caminati, Alessandro Vatrella, Paola Rogliani, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Tezepelumab: patient selection and place in therapy in severe asthma
Francesco Menzella, Sara Munari, Lorenzo Corsi, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 4
Open Access | Times Cited: 1
Successful Desensitization to Tezepelumab in a Polysorbate-Allergic Patient
S Bautista-Villanueva, María Mateos-Salvador, R Arrojo Fuentes, et al.
Journal of Investigational Allergology and Clinical Immunology (2024) Vol. 34, Iss. 6
Open Access | Times Cited: 1
The paradigm shift in drug development for atopic dermatitis: Addressing the variables of the equation leading to disease modification
Thomas Bieber
Annals of Allergy Asthma & Immunology (2024)
Open Access | Times Cited: 1
Personalized Medicine in Severe Asthma: Bridging the Gaps
Juan Luis García-Rivero, Ismael García‐Moguel
Open Respiratory Archives (2024) Vol. 6, Iss. 4, pp. 100368-100368
Open Access
Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs
Carlo Lombardi, Marcello Cottini, Annamaria Bosi, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 11
Open Access
Modern trends in asthma treatment
Samuel Genzor
Vnitřní lékařství (2024) Vol. 70, Iss. 8, pp. 513-516
Closed Access
Page 1

Scroll to top